| abstract |
THIS INVENTION IS RELATED TO THE INDIVIDUAL USE OF THE PROGESTERONE RECEIVER ANTAGONIST 11ß- (4- ACETILFENIL) -17ß-HIDROXI-17 ALFA- (1,1,2,2,2, -PENTAFLUOROETIL) -ESTRA - 4,9 -DIEN-3-ONA, OR A DERIVATIVE OR AN ANALOG OF THIS ACCEPTABLE FOR PHARMACEUTICAL USE, FOR PROFILAXIS AND TREATMENT OF BREAST CANCER MEDIATED BY BRCAI OR BRCA2, AND WITH A COMBINATION UNDERSTANDING THE RECEIVER OF PROGONA 11 - (4-ACETILFENIL) -17ß-HIDROXI-17ALFA- (1,1,2,2,2, -PENTAFLUOROETIL) - ESTRA-4, 9- DIEN-3-ONA, OR A DERIVATIVE OR AN ANALOG OF THIS ACCEPTABLE FOR PHARMACEUTICAL USE, WITH AT LEAST ONE PURE ANTIESTROGEN, FOR PROFILAXIS AND TREATMENT OF BREAST CANCER THROUGH BRCAI OR BRCA2, OVARIAN CANCER, ENDOMETRIC CANCER, GASTRIC CANCER, COLORRECT MYCELLAR, ENDECTURE COLLECTORS , MIOMA AND MENINGIOMA. |